127 related articles for article (PubMed ID: 8783156)
1. Rabies vaccine potency control: comparison of ELISA systems for antigenicity testing.
Rooijakkers EJ; Uittenbogaard JP; Groen J; Osterhaus AD
J Virol Methods; 1996 Apr; 58(1-2):111-9. PubMed ID: 8783156
[TBL] [Abstract][Full Text] [Related]
2. Development of competitive inhibition ELISA as an effective potency test to analyze human rabies vaccines and assessment of the antigenic epitope of rabies glycoprotein.
Soni D; Sahoo I; Mallya AD; Kamthe P; Sahai A; Goel SK; Kulkarni PS; Dhere RM
J Immunol Methods; 2021 May; 492():112939. PubMed ID: 33309752
[TBL] [Abstract][Full Text] [Related]
3. Standardization of an enzyme immunoassay for the in vitro potency assay of inactivated tissue culture rabies vaccines: determination of the rabies virus glycoprotein with polyclonal antisera.
Thraenhart O; Ramakrishnan K
J Biol Stand; 1989 Oct; 17(4):291-309. PubMed ID: 2613705
[TBL] [Abstract][Full Text] [Related]
4. Potency of veterinary rabies vaccines in The Netherlands: a case for continued vigilance.
Rooijakkers EJ; Nieuwenhuijs JH; Vermeulen AA; van Steenis G; Osterhaus AD
Vet Q; 1996 Dec; 18(4):146-50. PubMed ID: 8972063
[TBL] [Abstract][Full Text] [Related]
5. A time-resolved fluoroimmunoassay to assay the rabies virus glycoprotein: application for estimation of human rabies vaccine potency.
Lin G; Chen S; Zhao H; Liang J; Deng Q; Liang R; Guo X; Chen Z; Chen B; Liu T; Wu Y
Sci Rep; 2017 Aug; 7(1):7288. PubMed ID: 28779162
[TBL] [Abstract][Full Text] [Related]
6. G-protein based ELISA as a potency test for rabies vaccines.
Chabaud-Riou M; Moreno N; Guinchard F; Nicolai MC; Niogret-Siohan E; Sève N; Manin C; Guinet-Morlot F; Riou P
Biologicals; 2017 Mar; 46():124-129. PubMed ID: 28214171
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a potency test by ELISA for a rabies vaccine for animal use in Japan.
Gamoh K; Shimazaki Y; Senda M; Makie H; Itoh O; Muramatsu M; Hirayama N; Hatakeyama H
J Vet Med Sci; 2003 Jun; 65(6):685-8. PubMed ID: 12867727
[TBL] [Abstract][Full Text] [Related]
8. A simple immuno-capture ELISA to estimate rabies viral glycoprotein antigen in vaccine manufacture.
Nagarajan T; Reddy GS; Mohana Subramanian B; Rajalakshmi S; Thiagarajan D; Tordo N; Jallet C; Srinivasan VA
Biologicals; 2006 Mar; 34(1):21-7. PubMed ID: 16188454
[TBL] [Abstract][Full Text] [Related]
9. Competitive ELISA using a rabies glycoprotein-transformed cell line to semi-quantify rabies neutralizing-related antibodies in dogs.
Zhang S; Liu Y; Zhang F; Hu R
Vaccine; 2009 Mar; 27(15):2108-13. PubMed ID: 19356613
[TBL] [Abstract][Full Text] [Related]
10. Verification of the rabies virus glycoprotein lower limit of immunogenicity by serological assay.
Moreira WC; Machado NS; Freitas JFS; Almeida AECC; Moura WC
J Virol Methods; 2019 Feb; 264():31-37. PubMed ID: 30448319
[TBL] [Abstract][Full Text] [Related]
11. Effect of the contents and form of rabies glycoprotein on the potency of rabies vaccination in cattle.
Piza AT; Pieri KM; Lusa GM; Caporale GM; Terreran MT; Machado LA; Zanetti CR
Mem Inst Oswaldo Cruz; 2002 Mar; 97(2):265-8. PubMed ID: 12016455
[TBL] [Abstract][Full Text] [Related]
12. A novel site-II directed glycoprotein estimation ELISA to aid rabies vaccine manufacture for veterinary and human use.
Abhinay G; Dessain S; Srikanth A; Senthilkumar RL; Vidyasagar P; Praveen A; Chandrasekhar Reddy RV; Swapna Reddy E; Rajendra L
Vaccine; 2014 Jan; 32(2):209-13. PubMed ID: 24262315
[TBL] [Abstract][Full Text] [Related]
13. A DNA vaccine that encodes rabies virus glycoprotein lacking transmembrane domain enhances antibody response but not protection.
Gupta PK; Sharma S; Walunj SS; Patil AA; Rai A; Saini M
Acta Virol; 2006; 50(2):87-92. PubMed ID: 16808325
[TBL] [Abstract][Full Text] [Related]
14. Target cells for antibodies detection in rabies vaccine control.
Fontana D; Prieto C; Kratje R; Etcheverrigaray M
Vaccine; 2014 May; 32(24):2805-7. PubMed ID: 24631076
[TBL] [Abstract][Full Text] [Related]
15. Recombinant diabody-based immunocapture enzyme-linked immunosorbent assay for quantification of rabies virus glycoprotein.
Nimmagadda SV; Aavula SM; Biradhar N; Rao VS; Shanmugham R; Chandran D; Thirumeni N; Singanallur NB; Villuppanoor SA
Clin Vaccine Immunol; 2010 Aug; 17(8):1261-8. PubMed ID: 20573881
[TBL] [Abstract][Full Text] [Related]
16. Conformation-dependent accessibility of the linear epitopes located on the rabies virus glycoprotein.
Kontsekova E; Macikova I; Novak M; Dedek L; Vrzal V; Kontsek P
Viral Immunol; 1992; 5(3):213-20. PubMed ID: 1418319
[TBL] [Abstract][Full Text] [Related]
17. Measurement of rabies virus N protein in rabies vaccines.
Montaño-Hirose JA; Lafage M; Lafon M
Res Virol; 1995; 146(3):217-24. PubMed ID: 7481094
[TBL] [Abstract][Full Text] [Related]
18. A versatile in vitro ELISA test for quantification and quality testing of infectious, inactivated and formulated rabies virus used in veterinary monovalent or combination vaccine.
Sigoillot-Claude C; Battaglio M; Fiorucci M; Gillet D; Vimort AS; Giraud Y; Laurent S; Vaganay A; Poulet H
Vaccine; 2015 Jul; 33(32):3843-9. PubMed ID: 26144898
[TBL] [Abstract][Full Text] [Related]
19. An electrochemiluminescence assay for analysis of rabies virus glycoprotein content in rabies vaccines.
Smith TG; Ellison JA; Ma X; Kuzmina N; Carson WC; Rupprecht CE
Vaccine; 2013 Jul; 31(33):3333-8. PubMed ID: 23742991
[TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines.
Rooijakkers E; Groen J; Uittenbogarrd J; van Herwijnen J; Osterhaus A
Dev Biol Stand; 1996; 86():137-45. PubMed ID: 8785943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
